Insider Transactions in Q1 2022 at Johnson & Johnson (JNJ)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Open market or private sale
|
Direct |
34,555
-1.63%
|
$6,081,680
$176.27 P/Share
|
|
Mar 17
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
30,785
+18.23%
|
$3,078,500
$100.97 P/Share
|
|
Mar 15
2022
|
Robert J Decker VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
5,000
-8.73%
|
$875,000
$175.51 P/Share
|
|
Mar 15
2022
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+19.63%
|
$360,000
$72.54 P/Share
|
|
Feb 15
2022
|
William Hait EVP, Chief EI and Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,158
-4.93%
|
$686,070
$165.89 P/Share
|
|
Feb 15
2022
|
William Hait EVP, Chief EI and Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,128
+8.78%
|
-
|
|
Feb 15
2022
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
6,209
-3.76%
|
$1,024,485
$165.89 P/Share
|
|
Feb 15
2022
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,186
+7.4%
|
-
|
|
Feb 15
2022
|
Vanessa Broadhurst EVP, Global Corp Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
925
-5.58%
|
$152,625
$165.89 P/Share
|
|
Feb 15
2022
|
Vanessa Broadhurst EVP, Global Corp Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,557
+13.35%
|
-
|
|
Feb 15
2022
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
12,902
-4.98%
|
$2,128,830
$165.89 P/Share
|
|
Feb 15
2022
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
29,714
+10.3%
|
-
|
|
Feb 15
2022
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
26,472
-4.33%
|
$4,367,880
$165.89 P/Share
|
|
Feb 15
2022
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,965
+9.06%
|
-
|
|
Feb 15
2022
|
Mathai Mammen EVP, Pharm, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
3,366
-7.43%
|
$555,390
$165.89 P/Share
|
|
Feb 15
2022
|
Mathai Mammen EVP, Pharm, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
7,740
+14.59%
|
-
|
|
Feb 15
2022
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
6,242
-12.99%
|
$1,029,930
$165.89 P/Share
|
|
Feb 15
2022
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
15,806
+24.75%
|
-
|
|
Feb 15
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,699
-6.18%
|
$775,335
$165.89 P/Share
|
|
Feb 15
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,386
+12.02%
|
-
|
|
Feb 15
2022
|
Joseph J Wolk Exec VP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,319
-16.95%
|
$1,207,635
$165.89 P/Share
|
|
Feb 15
2022
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,793
+29.18%
|
-
|
|
Feb 15
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Payment of exercise price or tax liability
|
Direct |
1,843
-4.03%
|
$304,095
$165.89 P/Share
|
|
Feb 15
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
3,922
+7.9%
|
-
|
|
Feb 15
2022
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
8,841
-6.53%
|
$1,458,765
$165.89 P/Share
|
|
Feb 15
2022
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
18,064
+11.78%
|
-
|
|
Feb 15
2022
|
Robert J Decker VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
248
-1.58%
|
$40,920
$165.89 P/Share
|
|
Feb 15
2022
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
903
+5.43%
|
-
|
|
Feb 14
2022
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,857
-2.47%
|
$978,119
$167.37 P/Share
|
|
Feb 14
2022
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,190
+5.22%
|
-
|
|
Feb 14
2022
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
1,190
-1.0%
|
$199,920
$168.85 P/Share
|
|
Feb 14
2022
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
3,297
+2.71%
|
-
|
|
Feb 14
2022
|
Robert J Decker VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
263
-1.74%
|
$44,184
$168.85 P/Share
|
|
Feb 14
2022
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+5.43%
|
-
|
|
Feb 14
2022
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
792
-2.4%
|
$133,056
$168.85 P/Share
|
|
Feb 14
2022
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
2,885
+8.03%
|
-
|
|
Feb 14
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Payment of exercise price or tax liability
|
Direct |
1,520
-3.51%
|
$255,360
$168.85 P/Share
|
|
Feb 14
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
3,759
+7.98%
|
-
|
|
Feb 14
2022
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
871
-0.57%
|
$146,328
$168.85 P/Share
|
|
Feb 14
2022
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,407
+1.55%
|
-
|
|
Feb 14
2022
|
Vanessa Broadhurst EVP, Global Corp Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
902
-6.04%
|
$151,536
$168.85 P/Share
|
|
Feb 14
2022
|
Vanessa Broadhurst EVP, Global Corp Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,451
+14.1%
|
-
|
|
Feb 14
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-1.05%
|
$116,760
$168.85 P/Share
|
|
Feb 14
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,896
+2.78%
|
-
|
|
Feb 14
2022
|
Mathai Mammen EVP, Pharm, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,335
-5.85%
|
$392,280
$168.85 P/Share
|
|
Feb 14
2022
|
Mathai Mammen EVP, Pharm, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
7,418
+15.68%
|
-
|
|
Feb 14
2022
|
Joseph J Wolk Exec VP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
921
-3.5%
|
$154,728
$168.85 P/Share
|
|
Feb 14
2022
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,248
+10.99%
|
-
|
|
Feb 14
2022
|
William Hait EVP, Chief EI and Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,133
-1.36%
|
$526,344
$168.85 P/Share
|
|
Feb 14
2022
|
William Hait EVP, Chief EI and Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,790
+3.26%
|
-
|